ARTICLE | Company News
Integrated BioTherapeutics Inc., National Institutes of Health infectious news
October 13, 2008 7:00 AM UTC
Integrated BioTherapeutics received a five-year, $22 million contract from NIH's National Institute of Allergy and Infectious Diseases (NIAID) to develop a vaccine to prevent Ebola and Marburg viruses...